Liver scarring induced by polychlorinated biphenyl administration to mice previously treated with diethylnitrosamine.
Exposure of mice for 8 weeks to drinking water containing diethylnitrosamine (DEN) was accompanied by alterations in hepatocyte structure and varying degrees of liver nonparenchymal cell (NPC) proliferation. Eighteen and a half weeks after cessation of DEN exposure, there was a 47% incidence of hepatocellular nodules. Centrilobular hepatocyte hypertrophy occurred consistently in mice given intraperitoneal injections of the polychlorinated biphenyl (PCB) mixture Aroclor 1254. PCB administration to mice previously treated with DEN was not accompanied by increases in gross liver nodule incidence above that induced by DEN, but many more developing microscopic nodules within the liver were observed in DEN-treated mice given Aroclor 1254 than in mice treated only with DEN. Aroclor 1254 administration over a 16-week period to mice previously treated with DEN was accompanied by an 83% incidence of severe distortion of liver structure resulting from nodule formation, uneven patterns of hepatocyte growth, and extensive deposition of scar tissue containing proliferating bile ducts. Morphological evidence of intestinal metaplasia was observed in proliferating bile duct-like structures during an early stage of liver adenofibrosis.
D000818:Animals; D001140:Aroclors / Q000009:adverse effects / Q000494:pharmacology; D001835:Body Weight / Q000187:drug effects; D020111:Chlorodiphenyl (54% Chlorine); D002921:Cicatrix / Q000139:chemically induced / Q000473:pathology; D004052:Diethylnitrosamine / Q000009:adverse effects / Q000494:pharmacology*; D005355:Fibrosis; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D011078:Polychlorinated Biphenyls / Q000009:adverse effects / Q000494:pharmacology*
D001140:Aroclors; D020111:Chlorodiphenyl (54% Chlorine); D004052:Diethylnitrosamine; D011078:Polychlorinated Biphenyls